| Report Top | Up a Page | Previous | Next | Up a Map | TOC | Page Index | File Index | What's New | Page Bottom |
| Cognigen Corporation - Posters and Presentations : Cognigen Corporation : Clinical : Neoplasms Benign, Malignant and Unspecified : Posters : mTOR Inhibitors | published Wed, Nov 7, 2007 - 10:31 EST |
| Name | Description | Page Modified |
| Development of a Pharmacokinetic (PK) Model and Assessment of Patient (PT) Covariate Effects on Dose-Dependent PK following Different Dosing Schedules in Two Phase I Trials of AP23573 (AP), an mTOR Inhabitor | Presented at the 2005 ASCO Annual Meeting, Orlando, FL | Fri Nov 02 13:15:24 EDT 2007 |
| Cognigen Corporation - Posters and Presentations : Cognigen Corporation : Clinical : Neoplasms Benign, Malignant and Unspecified : Posters : mTOR Inhibitors | published Wed, Nov 7, 2007 - 10:31 EST |
| Report Top | Up a Page | Previous | Next | Up a Map | TOC | Page Index | File Index | What's New | Page Top |